ProPhase Labs Acquires Whole Genome Sequencing Firm For $14.5M

by Vandana Singh, Benzinga Editor

August 11, 2021 2:36 PM | 27 seconds read |

ProPhase Labs Inc PRPH has acquired privately-held Nebula Genomics for approximately $14.6 million in a combination of stock and cash.
Prophase will integrate Nebula's whole genome sequencing services with its clinical diagnostic testing services.
ThinkEquity, a division of Fordham Financial Management Inc, acted as advisor to ProPhase.
Nebula Genomics currently provides consumers access to affordable and secure whole-genome sequencing via its online portal.
Price Action: PRPH shares are down 9.92% at $6.91 during the market session on the last check Wednesday.